News

MDxHealth Reveals 2024 Financial Results and 2025 Outlook

MDxHealth Reveals 2024 Financial Results and 2025 Outlook

MDxHealth Reports Impressive Revenue Growth for 2024

MDxHealth SA (NASDAQ: MDXH) has recently unveiled its preliminary revenues for the fourth quarter and full year 2024, showcasing robust performance driven by significant year-over-year gains. The Company anticipates fourth quarter revenues around $24.7 million and full-year figures of approximately $90 million, indicating an impressive growth rate of 28% for both periods.

Key Metrics Demonstrate Strong Operational Growth

In evaluating its operational progress, MDxHealth reported billing of 11,789 tissue-based units and 12,036 liquid-based units during the fourth quarter. These figures represent astounding year-over-year growth of 50% in tissue-based units and 10% in liquid-based units. For the entire year, the Company recorded billing of 41,586 tissue-based units and 45,700 liquid-based units, culminating in growth rates of 31% and 28%, respectively. Notably, the cash balance stood firm at $46.8 million at the end of the year, reflecting a healthy liquidity position.

2025 Revenue Guidance and Optimistic Outlook

Alongside its 2024 financial results, MDxHealth is also issuing revenue guidance for 2025, projecting revenues in the range of $108 to $110 million. This forecast suggests a growth rate of 20% to 22% compared to the previous year. The Company's CEO, Michael K. McGarrity, expressed confidence in the Company’s growth trajectory, emphasizing that the robust sales channels and expanded offerings tailored to its urology client base will be pivotal in sustaining this growth. He noted, "Our sustained execution on growth initiatives positions us strongly for the year ahead, with our adjusted EBITDA expected to reach profitability within the first half of 2025."

Innovations in Precision Diagnostics

MDxHealth has positioned itself as an industry leader in the field of precision diagnostics. By integrating genomic, epigenetic, and other molecular technologies, the Company provides timely and actionable information that is vital for personalizing cancer diagnosis and treatment. The focal point of MDxHealth's offerings is its advanced tests aimed at diagnosing urologic cancers and associated conditions.

Corporate Structure and Global Presence

The Company is headquartered in Irvine, California, and operates a laboratory in Plano, Texas. Additionally, it maintains its European headquarters in Herstal, Belgium. This broad geographical footprint allows MDxHealth to better serve its diverse clientele globally.

Upcoming Reporting Schedule

Looking ahead, the Company has established a comprehensive 2025 reporting calendar that includes key dates: on February 26, it will disclose 2024 fiscal year results, followed by Q1 2025 financial results on May 14. The Annual General Shareholders' Meeting is scheduled for May 29, and the second quarter results will be announced on August 14. This structured approach reinforces MDxHealth's commitment to transparency and stakeholder communication.

Financial Review Insights

The preliminary revenue data for the year ending December 31, 2024, is based on internal reports and has yet to undergo final auditing processes. The Company remains dedicated to refining its financial reporting and is prepared for the possibility of adjustments that may arise during official audits.

Frequently Asked Questions

What were MDxHealth's total anticipated revenues for 2024?

MDxHealth expects to report approximately $90.0 million in total revenues for the year 2024.

How much growth did the company achieve in its tissue and liquid unit sales?

The company achieved a 50% growth in tissue-based units and a 10% growth in liquid-based units during the fourth quarter.

What is the revenue guidance for MDxHealth in 2025?

MDxHealth is forecasting revenues between $108 million and $110 million for 2025.

Where are MDxHealth's headquarters and lab operations located?

MDxHealth has its U.S. headquarters in Irvine, California, with additional labs in Plano, Texas, and its European headquarters in Herstal, Belgium.

What upcoming events should investors be aware of?

Investors can look forward to several key reporting dates, including the 2024 fiscal year results on February 26, 2025, and quarterly updates throughout the year.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 82

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 58

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 121

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 0

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 65

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 35

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
TDH's First-Half Revenue Grew, but Margins Vanished

Updated Category News Views 106

A rental business can add tenants and still march backward, and TDH Holdings just demonstrated the ugly math. For the six months ended June 30, 2026, revenue from continuing operations rose 26.45% to $0.74 million. That is the pleasant number, and it deserves exactly one polite nod. Everything beneath it looks far less comfortable: costs climbed faster than revenue, gross...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 108

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading

Top 5 Most Recently Viewed Articles

European Wax Center's Inducement Grants for New Executives

Updated Category News Views 140

Overview of Inducement Grants European Wax Center, Inc. (NASDAQ: EWCZ), known as a leading provider of out-of-home waxing services across the United States, has recently made headlines with its strategic inducement grants. This move comes in light of the recent appointments of key executives, aiming to bolster the company's leadership and operational capabilities....

Continue Reading
Enhancing AI Security: Check Point and Microsoft Partnership

Updated Category News Views 283

Enhancing AI Security Through Strategic Collaboration Check Point Software Technologies Ltd. (NASDAQ: CHKP), a renowned global leader in cyber security solutions, has embarked on an exciting partnership with Microsoft. This collaboration aims to inject enterprise-grade AI security into the Microsoft Copilot Studio, ensuring that organizations can innovate safely and...

Continue Reading
TransMontaigne Partners Strengthen Credit Facility with Extension

Updated Category News Views 238

TransMontaigne Partners LLC Enhances Credit Facility Terms TransMontaigne Partners LLC has recently announced a significant development in its financial strategy. The company has officially closed Amendment No. 4 to its existing Credit Agreement, which illustrates its commitment to optimizing financial operations and enhancing financial stability. Understanding the...

Continue Reading
Red Cross Issues Urgent Call for Blood Donations Beyond Holidays

Updated Category News Views 119

Urgent Appeal for Blood Donations Post-Holiday Season The American Red Cross is currently confronting the threat of a significant blood shortage. As the busy holiday season comes to a close, blood donation rates have plummeted. Unfortunately, the rate at which blood products are being distributed now exceeds the number of donations received, raising concerns about the...

Continue Reading
Weight Loss Drugs Linked to Genetic Hair Loss in Men

Updated Category News Views 34

When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...

Continue Reading